Tag: QUEST trial

Neuros Medical announces completion of 90-day primary endpoints in QUEST pivotal...

Neuros Medical has announced the completion of its QUEST pivotal trial’s 90-day primary endpoints, according to a company press release. QUEST outcomes will remain...
neuros quest study

Neuros Medical completes enrolment in QUEST pivotal study of novel post-amputation...

Neuros Medical—a medical device company developing novel high-frequency nerve block technology for patients with intractable post-amputation pain—has announced the completion of enrolment in its pivotal QUEST...
neuros quest study

Neuros Medical gains FDA Breakthrough Device designation for Altius nerve block...

Neuros Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the use of its novel, high-frequency nerve block...